[go: up one dir, main page]

Schleef et al., 2000 - Google Patents

Protease Inhibitor 10 Inhibits Tumor Necrosis Factor α-induced Cell Death: EVIDENCE FOR THE FORMATION OF INTRACELLULAR HIGHM r PROTEASE INHIBITOR …

Schleef et al., 2000

View HTML @Full View
Document ID
4369649680304999386
Author
Schleef R
Chuang T
Publication year
Publication venue
Journal of Biological Chemistry

External Links

Snippet

Protease inhibitor 10 (PI10) is a member of the ovalbumin family of serine protease inhibitors (ov-serpin) that is expressed at elevated levels in patients with acute myeloid leukemia and chronic myelomonocytic leukemia. Based upon the ability of the related serpin …
Continue reading at www.jbc.org (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/558—Immunoassay; Biospecific binding assay using diffusion or migration of antigen or antibody
    • G01N33/561—Immunoelectrophoresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases

Similar Documents

Publication Publication Date Title
Grawunder et al. Requirement for an interaction of XRCC4 with DNA ligase IV for wild-type V (D) J recombination and DNA double-strand break repairin vivo
Li et al. Ubiquitination of RIP is required for tumor necrosis factor α-induced NF-κB activation
Lin et al. Inhibition of calcineurin phosphatase activity by a calcineurin B homologous protein
Rajendra et al. Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53
Kim et al. Differential regulation of the dopamine D2and D3 receptors by G protein-coupled receptor kinases and β-arrestins
Zeng et al. Death receptor 6 induces apoptosis not through type I or type II pathways, but via a unique mitochondria-dependent pathway by interacting with Bax protein
Roberts et al. Degradation of the basic helix-loop-helix/Per-ARNT-Sim homology domain dioxin receptor via the ubiquitin/proteasome pathway
Lill et al. The evolutionarily conserved N-terminal region of Cbl is sufficient to enhance down-regulation of the epidermal growth factor receptor
Kimura et al. Accumulation of GTP-bound RhoA during cytokinesis and a critical role of ECT2 in this accumulation
Kamitani et al. Covalent modification of PML by the sentrin family of ubiquitin-like proteins
Zheng et al. Differential regulation of Pyk2 and focal adhesion kinase (FAK): the C-terminal domain of FAK confers response to cell adhesion
Zagha et al. DPP10 modulates Kv4-mediated A-type potassium channels
Inuzuka et al. SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction
Hong et al. Underglycosylation of ATF6 as a novel sensing mechanism for activation of the unfolded protein response
Sironi et al. STAT1-induced apoptosis is mediated by caspases 2, 3, and 7
Cho et al. Morphological adjustment of senescent cells by modulating caveolin-1 status
Rangasamy et al. SUMO-1 modification of bovine papillomavirus E1 protein is required for intranuclear accumulation
Wu et al. β-TrCP mediates the signal-induced ubiquitination of IκBβ
Zhang et al. Identification of an overlapping binding domain on Cdc20 for Mad2 and anaphase-promoting complex: model for spindle checkpoint regulation
Bassermann et al. NIPA defines an SCF-type mammalian E3 ligase that regulates mitotic entry
Strous et al. Growth hormone-induced signal transduction depends on an intact ubiquitin system
Su et al. Modulation of the eukaryotic initiation factor 2 α-subunit kinase PERK by tyrosine phosphorylation
Lee et al. Characterization of the deubiquitinating activity of USP19 and its role in endoplasmic reticulum-associated degradation
van Kerkhof et al. The ubiquitin ligase SCF (βTrCP) regulates the degradation of the growth hormone receptor
Song et al. Human Ku70 interacts with heterochromatin protein 1α